Corporate / M&A

IP / IT

Capital Markets

Employment and Executive Compensation

Bioversys

Homburger News

20250129_Bioversys

On January 29, 2025, BioVersys AG, a clinical-stage biopharmaceutical company developing and commercializing novel antibacterial products for life-threatening infections domiciled in Basel, Switzerland, announced the launch of its Initial Public Offering (IPO) on SIX Swiss Exchange, the publication of the offer price and the start of the bookbuilding process. The IPO comprises a primary offering targeting gross proceeds of CHF 80 m (including an over-allotment option targeting gross proceeds of CHF 5 m). The implied market capitalization of the company, assuming all offered shares are sold in the IPO and the over-allotment option is exercised in full, is approximately CHF 212.9 m. The first day of trading is expected to be February 7, 2025.
BioVersys focuses on identifying, developing and commercializing novel antibacterial products for serious life-threatening infections caused by multi-drug resistant (MDR) bacteria. The Company&#8217;s most advanced R&amp;D programs address nosocomial pneumonia and blood stream infections caused by Acinetobacter baumannii (BV100, phase 3-ready) and tuberculosis (alpibectir, phase 2a). In addition to its domicile in the biotech hub in Basel, Switzerland, BioVersys has operations in in Lille, France, Delaware, United States and Guangzhou, China.
Citigroup Global Markets Limited, UBS AG and Stifel Europe AG are acting as Joint Global Coordinators and Joint Bookrunners on the IPO, Mirabaud &amp; Cie SA and Octavian AG as Selling Agents.
Homburger is advising BioVersys on all aspects of the IPO as lead counsel. The Homburger team is co-led by Dieter Gericke and Lorenzo Togni and includes Thierry Burckhardt, Magda Aref, Simone Schmid, Raphael Linder, Harun Cetin and Leander Etter (all Corporate / M&amp;A and Capital Markets). Luca Dal Molin and Kristina Martinovic (both IP / IT) are providing intellectual property advice, Jeremy Reichlin (Employment and Executive Compensation) is providing employment and executive compensation advice, and Reto Heuberger and Philippe Weber (both Tax) are providing tax advice.

Homburger advises BioVersys AG on its IPO on SIX Swiss Exchange

Financing and Investment Products

Meyer Burger

Homburger News 

Share-Image Teamplate Deals-and-Cases

On April 3, 2024, Meyer Burger Technology AG (SIX: MBTN) announced the successful completion of its rights offering, raising gross proceeds of CHF 206.75 m. Shares not subscribed by shareholders were placed with institutional investors at the prevailing market price.
Homburger acted as legal and tax counsel to Meyer Burger in this transaction. The Homburger team was co-led by Dieter Gericke and Daniel Häusermann (both Corporate / M&amp;A, Capital Markets) and included Lorenzo Togni (Capital Markets), Jasmin Künzle, Magda Aref, Hans Glent Abildgaard, Thomas Romelli, Cédric Berger, Oliver Dalla Palma, Daniel Wenzinger and Alexander Giger (all Corporate / M&amp;A, Capital Markets), Miguel Sogo and Oliver Mrose (both Corporate / M&amp;A), Eduard De Zordi and Daniel Hulmann (both Financing and Investment Products) as well as Stefan Oesterhelt (Tax).

Homburger advised Meyer Burger on its CHF 206.75 m rights offering

Competition

Clear-Channel_web-640x140

20230331_Clearchannel

On March 31, 2023, Clear Channel Outdoor Holdings, Inc. (NYSE: CCO), a global out-of-home advertising company, announced that it has completed the sale of its business in Switzerland to Goldbach Group AG, an affiliate of TX Group AG, for CHF 86.0 m.
Homburger advises Clear Channel Outdoor Holdings, Inc. with regard to all Swiss legal aspects of this transaction. The Homburger team is led by Daniel Hasler and comprises Andrea Grimm Widmer, Magda Aref, Thierry Burckhardt and Mike Lerchmüller (all Corporate / M&amp;A), Richard Stäuber, Allegra Arnold and Katharina Bratvogel (all Competition), Eduard De Zordi and Sarah Fasel (both Financing and Investment Products), Peter Müller (Tax), Gregor Bühler and Philippe Baumann (both IP / IT).

Homburger advises Clear Channel on the successful closing of the sale of its Swiss business to TX Group

Magda
Aref

Homburger advises BioVersys AG on its IPO on SIX Swiss Exchange

Homburger advised Meyer Burger on its CHF 206.75 m rights offering

Homburger advises Clear Channel on the successful closing of the sale of its Swiss business to TX Group

Die Abschaffung der Sachübernahmevorschriften im neuen Aktienrecht

Digitale Originale dank NFTs?

Selektives opting-up und die öffentliche Angebotspflicht

Join the Team

Magda Aref

Career

Languages

Bar Registration

Teams

MagdaAref

Homburger advises BioVersys AG on its IPO on SIX Swiss Exchange

Homburger advised Meyer Burger on its CHF 206.75 m rights offering

Homburger advises Clear Channel on the successful closing of the sale of its Swiss business to TX Group

Die Abschaffung der Sachübernahmevorschriften im neuen Aktienrecht

Digitale Originale dank NFTs?

Selektives opting-up und die öffentliche Angebotspflicht

Join the Team

Magda Aref

Career

Languages

Bar Registration

Teams

Magda
Aref